We are live on ! Find out more
CRC

Curi RMB Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 18.93%
This Fund
S&P 500
This Quarter Est. Return
+4.61%
1 Year Est. Return
+18.93%
3 Year Est. Return
+60.65%
5 Year Est. Return
+73.12%
10 Year Est. Return
+312.51%
AUM
$4.2B
AUM Growth
+$292M
Cap. Flow
+$165M
Cap. Flow %
3.92%
Top 10 Hldgs %
16.5%
Holding
1,014
New
124
Increased
300
Reduced
392
Closed
121

Sector Composition

Rank Sector Weight
1 Financials 24.29%
2 Technology 7.55%
3 Industrials 7.5%
4 Healthcare 7.32%
5 Consumer Discretionary 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDS icon
351
Telephone and Data Systems
TDS
$3.82B
$2.26M 0.05%
+82,389
New +$2.23M
EHI
352
Western Asset Global High Income Fund
EHI
$175M
$2.26M 0.05%
247,386
+50,589
+26% +$473K
HOMB icon
353
Home BancShares
HOMB
$6.23B
$2.26M 0.05%
100,000
-101,171
-50% -$2.34M
PHLT
354
DELISTED
Performant Healthcare Inc
PHLT
$2.24M 0.05%
1,041,628
-247,177
-19% -$644K
IJH icon
355
iShares Core S&P Mid-Cap ETF
IJH
$122B
$2.23M 0.05%
57,350
+1,380
+2% +$53.3K
PF
356
DELISTED
Pinnacle Foods, Inc.
PF
$2.23M 0.05%
34,226
-3,276
-9% -$202K
EVV
357
Eaton Vance Limited Duration Income Fund
EVV
$1.06B
$2.21M 0.05%
+175,240
New +$2.25M
BFZ
358
DELISTED
BlackRock CA Municipal Income Trust
BFZ
$2.2M 0.05%
168,627
+33,040
+24% +$429K
CART
359
DELISTED
Carolina Trust BancShares
CART
$2.19M 0.05%
265,584
+135,000
+103% +$1.12M
RARE icon
360
Ultragenyx Pharmaceutical
RARE
$2.45B
$2.18M 0.05%
28,353
-16,825
-37% -$1.09M
AIMT
361
DELISTED
Aimmune Therapeutics
AIMT
$2.17M 0.05%
80,633
+4,665
+6% +$143K
IVW icon
362
iShares S&P 500 Growth ETF
IVW
$73.8B
$2.17M 0.05%
53,296
NEOG icon
363
Neogen
NEOG
$2.63B
$2.17M 0.05%
54,002
-54,780
-50% -$2.02M
KMB icon
364
Kimberly-Clark
KMB
$36.3B
$2.15M 0.05%
20,396
+236
+1% +$24.5K
WFC icon
365
Wells Fargo
WFC
$261B
$2.13M 0.05%
38,371
-465
-1% -$24.9K
BLUE
366
DELISTED
bluebird bio
BLUE
$2.13M 0.05%
1,045
-444
-30% -$1.01M
TDOC icon
367
Teladoc Health
TDOC
$1.22B
$2.11M 0.05%
36,383
+6,114
+20% +$299K
UCBA
368
DELISTED
United Community Bancorp
UCBA
$2.11M 0.05%
77,500
SAGE
369
DELISTED
Sage Therapeutics
SAGE
$2.1M 0.05%
13,433
-6,555
-33% -$1.03M
FGP
370
DELISTED
Ferrellgas Partners, L.P.
FGP
$2.1M 0.05%
625,000
-397,900
-39% -$1.4M
ISD
371
PGIM High Yield Bond Fund
ISD
$415M
$2.09M 0.05%
149,264
-18,150
-11% -$256K
MDRX
372
DELISTED
Veradigm Inc. Common Stock
MDRX
$2.09M 0.05%
174,109
+92,952
+115% +$1.15M
MNK
373
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$2.08M 0.05%
+111,605
New +$1.78M
MNRO icon
374
Monro
MNRO
$383M
$2.08M 0.05%
35,821
-41,408
-54% -$2.34M
BA icon
375
Boeing
BA
$171B
$2.08M 0.05%
6,186
+160
+3% +$55K

Similar funds

Curi RMB Capital's Q2 2018 Portfolio in Review

As of Q2 2018, Curi RMB Capital held 1,014 positions worth $4.2B, up 7.5% from $3.91B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Curi RMB Capital deployed $165M of net new capital in Q2 2018, opening 124 new positions and adding to 300 existing holdings. Its largest new stake was Business First Bancshares: 869,550 shares worth $22.9M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Casey's General Stores, an estimated $15.1M trimmed.

  • Curi RMB Capital's largest Q2 2018 buy was Business First Bancshares: 869,550 shares worth $22.9M.
  • Curi RMB Capital added most to FB Financial Corp in Q2 2018, an estimated $23.5M increase.
  • Curi RMB Capital's biggest Q2 2018 reduction was Casey's General Stores, cutting an estimated $15.1M.
  • Curi RMB Capital fully exited Atlantic Coast Financial Corporation in Q2 2018, selling an estimated $8.61M.
  • Curi RMB Capital's ten largest holdings make up 16% of its $4.2B portfolio in Q2 2018.
  • Curi RMB Capital opened 124 new positions and closed 121 in Q2 2018.
  • Curi RMB Capital's portfolio value rose 7.5% quarter-over-quarter to $4.2B.

Based on Curi RMB Capital's 13F filing for Q2 2018, filed 13 Aug 2018.